New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
A Standard patent application filed on 20 April 1993 credited to Hamanaka, Ernest S
Details
Application number :
40283
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
Inventor :
Hamanaka, Ernest S
Agent name :
SPRUSON & FERGUSON
Address for service :
GPO Box 3898 SYDNEY NSW 2001
Filing date :
20 April 1993
Associated companies :
Applicant name :
Pfizer Inc.
Applicant address :
235 East 42nd Street New York New York 10017 United States Of America